Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Amarin Seeks ITC Action Against Products 'Cloaked' As Dietary Supplements

30 Aug 2017

• By Sue Sutter

US International Trade Commission ITC in Washington DC — Amarin seeks ITC review of 18 companies' omega0-3 products.

Related Content

Off-Label Litigation: Amarin Sues FDA In Bid To Promote Vascepa Fish Oil

07 May 2015

Off-Label Unleashed? Amarin Win Suggests Firms Still Need Strong Data To Skirt FDA

07 Aug 2015

Off-Label Promotion Settlement Includes Optional Preclearance Process

09 Mar 2016

Related Companies

Amarin Corp plc

GSK plc

Kowa Company, Ltd.

Additional Topics

United States Legal Issues Drug Approval Standards Dietary Supplements OTC Drugs Consumer Cardiovascular Metabolic Disorders BioPharmaceutical

More from Legal & IP

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.